Houlihan Lokey Q2 Earnings Call Highlights

Houlihan Lokey reported fiscal Q2 2027 revenue of $692 million, up 5% year over year, while adjusted EPS was unchanged at $1.85. Management said the normalizing market environment continued into October but cited caution over macroeconomic volatility, geopolitical instability and ongoing dislocation in the software sector.

Analysis

The key signal is a possible gap between improving activity and earnings conversion: revenue growth without EPS growth leaves open whether costs, business mix, or compensation absorbed the incremental fees. Segment results and expense trends are needed before treating this as a durable margin problem. Management’s reference to conditions continuing into October offers near-term evidence of activity, but one month does not establish a sustained recovery.

For the next 1–3 months, the main swing factor is whether transaction execution and fee realization improve enough to convert activity into earnings. A prolonged software-sector dislocation could cut M&A and financing activity even as restructuring work rises; that is not automatically a net benefit, since mandates may be smaller, delayed, or contested. Over 6–18 months, a broad deal-market recovery would favor advisory platforms, while persistent volatility would keep results dependent on deal timing and mix. Peers such as Evercore, Lazard, and PJT Partners offer potential relative-value comparables, but segment and cost data are needed before asserting HLI is better or worse positioned. The earnings signal is mixed, not sufficient on its own for a directional valuation call.

Key Decisions for Investors

• Avoid chasing HLI on the activity commentary alone; wait for evidence in the next results that revenue growth is translating into EPS or improved expense leverage. Verify segment fees, compensation/operating expense growth, and any change in deal pipeline or backlog.
• Treat HLI as a watch rather than an immediate long/short. A constructive entry setup would require sustained activity alongside improving earnings conversion; a reversal in activity commentary or further revenue/EPS divergence would falsify that thesis.
• For relative-value work, compare HLI with Evercore, Lazard, and PJT Partners using advisory mix, expense growth, and earnings revisions—not headline revenue growth alone. No pair trade is justified without that comparison and current valuation data.
• Monitor software deal completion and restructuring activity over the next 1–3 months: weaker M&A/financing without a meaningful offset from restructuring would be a downside catalyst; broad-based execution and improving margins would support reassessment.